Evidence map›Paper›PMID 32019158›Full record

Trial reportNutrients2020

Christopher J Martoni, Shalini Srivastava, Gregory J Leyer

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 4 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 4 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Efficacy and dose response ofWorld journal of gastroenterology · 2023
    Trial
  9. Trial
  10. Trial
  11. Frontiers in immunology · 2021
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Microbiome and chronic pelvic pain in women: a mini-review.Human reproduction (Oxford, England) · 2026
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher J MartoniUAS Laboratories LLC, 4375 Duraform Lane, Windsor, WI 53598, USA.
Shalini SrivastavaVedic Lifesciences, 203 Morya Landmark1, New Link Road, Andheri W, Mumbai 400053, India.
Gregory J LeyerUAS Laboratories LLC, 4375 Duraform Lane, Windsor, WI 53598, USA.
Vedic Lifesciences (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This randomized, double-blind, placebo-controlled, multi-center study investigated the clinical efficacy of two probiotic strains on abdominal pain severity and symptomology in irritable bowel syndrome (IBS). Three hundred and thirty adults, aged 18 to 70 years, with IBS according to Rome IV criteria were allocated (1:1:1) to receive placebo,

Indexed as

Bifidobacterium animalisLactobacillus acidophilusAbdominal PainAdolescentAdultAgedDouble-Blind MethodFemaleHumansIrritable Bowel SyndromeMaleMiddle AgedProbioticsSeverity of Illness IndexTreatment OutcomeYoung Adultabdominal painbowel habitsirritable bowel syndromemicrobiomeprobioticRandomized controlled trial

Identifiers

PMID32019158
PMCPMC7071206
OpenAlexW3004290421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.